Name: ABBVIE INC (4AB) Stock
Brand: ABBVIE INC
Rating: 5.5 (3 reviews)

Question 1

What does ABBVIE INC do?

Accepted Answer

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 55,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.

Question 2

What is the stock price of ABBVIE INC today?

Accepted Answer

The current stock price of 4AB.DE is 190.6 EUR.

Question 3

Does ABBVIE INC pay dividends?

Accepted Answer

ABBVIE INC (4AB.DE) has a dividend yield of 3.09%. The yearly dividend amount is currently 5.32.

Question 4

What is the ChartMill rating of ABBVIE INC stock?

Accepted Answer

4AB.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.

Question 5

What do analysts say about ABBVIE INC (4AB.DE) stock?

Accepted Answer

38 analysts have analysed 4AB.DE and the average price target is 213.25 EUR. This implies a price increase of 11.88% is expected in the next year compared to the current price of 190.6.

Question 6

Is ABBVIE INC (4AB.DE) stock a good buy?

Accepted Answer

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 4AB.DE.

Question 7

What is the market capitalization of 4AB stock?

Accepted Answer

ABBVIE INC (4AB.DE) has a market capitalization of 336.86B EUR. This makes 4AB.DE a Mega Cap stock.

ABBVIE INC (4AB.DE) Stock Price, Forecast & Analysis

4AB.DE Latest News, Press Relases and Analysis